ATH 0.00% 0.3¢ alterity therapeutics limited

LLY change at the top., page-28

  1. 5,922 Posts.
    lightbulb Created with Sketch. 151
    And if they get the go ahead to run a trial in the EU or elsewhere, it is game on P3 HD trial. Then Prana becomes a neurodegeneration drug developer with a wide platform of drugs to follow.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.